Stuart Walter Peltz

Co-Founder at PTC Therapeutics, Inc.

Stuart Walter Peltz

Stuart Walter Peltz

Co-Founder at PTC Therapeutics, Inc.

Biography

Stuart Walter Peltz founded PTC Therapeutics, Inc. He is Chief Executive Officer & Director at this company. Dr. Peltz is also on the board of BioNJ, Inc., PTC Therapeutics International Ltd. and PTC Therapeutics Ltd. In his past career he occupied the position of Professor-Molecular Genetics & Microbiology at Robert Wood Johnson Medical School and Professor at the University of Medicine & Dentistry of New Jersey. He received a doctorate from the University of Wisconsin.

Overview
Career Highlights

PTC Therapeutics, Inc.

RelSci Relationships

2841

Number of Boards

7

Birthday

1960

Age

61

Contact Data
Trying to get in touch with Stuart Walter Peltz? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Stuart Walter Peltz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at PTC Therapeutics, Inc.

Relationship likelihood: Strong

Director, Chief Medical Officer, Viralclear Pharmaceuticals, Inc at BioSig Technologies, Inc.

Relationship likelihood: Strong

Principal Deputy Director at National Institutes of Health

Relationship likelihood: Strong

Professor at Yale University

Relationship likelihood: Strong

Chief Executive Officer & Director at TScan Therapeutics, Inc.

Relationship likelihood: Strong

Chief Business Officer at PTC Therapeutics, Inc.

Relationship likelihood: Strong

Executive Advisor at LRVHealth Ventures LLC

Relationship likelihood: Strong

Director at National Institutes of Health

Relationship likelihood: Strong

Chief Development Officer at PTC Therapeutics, Inc.

Relationship likelihood: Strong

Former President-Europe & Canada Region at Merck & Co., Inc.

Relationship likelihood: Strong

Paths to Stuart Walter Peltz
Potential Connections via
Relationship Science
You
Stuart Walter Peltz
Co-Founder at PTC Therapeutics, Inc.
Education
Ph.D. from the McArdle Laboratory for Cancer Research

The University of Wisconsin–Madison has long been recognized as one of America's great universities. A public, land-grant institution, UW–Madison offers a complete spectrum of liberal arts studies, professional programs and student activities. Spanning 936 acres along the southern shore of Lake Mendota, the campus is located in the city of Madison.

Memberships
Fellow
Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Career History
Co-Founder
1998 - Current

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Professor-Molecular Genetics & Microbiology
1991 - Prior
Professor
Prior

The University of Medicine and Dentistry of New Jersey (UMDNJ) was a state-run health sciences institution of New Jersey, United States. It had eight distinct academic units. It formed an academic health sciences centre.

Boards & Committees
Member, Board of Directors
Current

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Member, Emerging Companies Section Governing Board
2010 - 2015

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Political Donations
$100
2016

Former Senator from New York

Transactions
Details Hidden

PTC Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

PTC Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

PTC Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stuart Walter Peltz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stuart Walter Peltz's profile does not indicate a business or promotional relationship of any kind between RelSci and Stuart Walter Peltz.